Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Mar 2016 09:00

RNS Number : 5176R
Exova Group PLC
09 March 2016
 

Notification of Transactions of Directors / Persons Discharging Managerial Responsibility and Connected Persons

 

1.

Name of the issuer

 

 

EXOVA GROUP PLC

 

2.

State whether the notification relates to

(i) a transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or

(iii) in accordance with paragraph 26 of the Model Code

 

(i) ABOVE

 

3.

Name of person discharging managerial responsibilities/director

 

 

IAN EL-MOKADEM

 

 

 

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

IAN EL-MOKADEM AND CATHRYN EL-MOKADEM (SPOUSE)

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest1

 

 

NOTIFICATION IS IN RESPECT OF A JOINT HOLDING OF THE PERSONS REFERRED TO IN SECTIONS 3 AND 4

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

ORDINARY SHARES

 

 

 

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

LYNCHWOOD NOMINEES LIMITED

 

 

8

State the nature of the transaction

 

 

 

PURCHASE

 

9.

Number of shares, debentures or financial instruments relating to shares acquired

 

 

50,000

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.02%

 

11.

Number of shares, debentures or financial instruments relating to shares disposed

 

 

N/A

 

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

145.98p

14.

Date and place of transaction

 

DATE: 8 MARCH 2016

PLACE: LONDON

 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

2,050,000 ORDINARY SHARES

(INCLUDING 88,569 SHARES HELD JOINTLY WITH SPOUSE) (0.82% TOTAL PERCENTAGE HOLDING)

16.

Date issuer informed of transaction

 

 

 

8 MARCH 2016

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17

Date of grant

 

N/A

 

18.

Period during which or date on which exercisable

 

N/A

 

19.

Total amount paid (if any) for grant of the option

 

N/A

 

20.

Description of shares or debentures involved (class and number)

 

N/A

 

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

N/A

22.

Total number of shares or debentures over which options held following notification

 

 

 

N/A

 

23.

Any additional information

 

N/A

 

24.

Name of contact and telephone number for queries

 

NEIL MACLENNAN - COMPANY SECRETARY

0131 333 8053

 

Name of authorised officer of issuer responsible for making notification

 

 

NEIL MACLENNAN - COMPANY SECRETARY

 

Date of notification - 9 MARCH 2016

 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUKOWRNKAORRR
Date   Source Headline
24th May 20173:11 pmRNSDirector/PDMR Shareholding
24th May 20171:40 pmRNSResult of AGM
24th May 20171:32 pmRNSAGM Statement
24th May 201712:34 pmRNSForm 8.5 (EPT/RI) - Amendment
24th May 201712:02 pmRNSForm 8.5 (EPT/NON-RI) - Exova Group Plc
24th May 201712:00 pmRNSForm 8.5 (EPT/RI) - Exova Group Plc
24th May 201711:08 amRNSForm 8.3 - Exova Group PLC
24th May 201710:57 amRNSDirector Declaration
24th May 201710:32 amRNSForm 8.5 (EPT/RI)
24th May 201710:13 amRNSForm 8.5 (EPT/RI)
24th May 20179:45 amRNSForm 8.3 - EXOVA GROUP PLC
24th May 20177:00 amRNSTrading Statement
23rd May 201712:20 pmRNSForm 8.5 (EPT/RI) - Exova Group Plc
23rd May 201711:57 amRNSForm 8.3 - Exova Group Plc
23rd May 201710:35 amRNSForm 8.5 (EPT/RI)
22nd May 20173:30 pmRNSForm 8.3 - EXO LN
22nd May 20173:18 pmRNSForm 8.3 - Exova Group Plc
22nd May 201711:52 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
22nd May 201710:34 amRNSForm 8.5 (EPT/RI)
19th May 20172:53 pmBUSForm 8.3 - Exova Group Plc
19th May 20172:03 pmRNSForm 8.3 - [Exova Group Plc]
19th May 20171:57 pmRNSForm 8.3 - Exova Group Plc
19th May 20171:11 pmRNSForm 8.5 (EPT/RI)
19th May 20171:03 pmRNSForm 8.3 - EXOVA GROUP PLC
19th May 201711:35 amRNSForm 8.5 (EPT/RI) Exova Group Plc
19th May 201711:26 amRNSForm 8.5 (EPT/RI)
18th May 201712:22 pmRNSForm 8.3 - Exova Group Plc
18th May 201711:53 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
18th May 201711:52 amRNSForm 8.5 (EPT/NON-RI) - Exova Group Plc
18th May 201711:19 amRNSForm 8.5 (EPT/RI)
18th May 201711:12 amRNSForm 8.3 - Exova Group PLC
18th May 201710:50 amRNSForm 8.5 (EPT/RI)
18th May 20178:30 amRNSAcquisition
17th May 20174:52 pmRNSForm 8.5 (EPT/RI) - Amendment
17th May 20172:56 pmRNSForm 8.3 - Exova Group Plc
17th May 20172:25 pmBUSForm 8.3 - Exova Group Plc
16th May 20172:54 pmBUSForm 8.3 - Exova Group Plc
16th May 201711:52 amRNSForm 8.5 (EPT/RI)
16th May 201711:49 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
16th May 201710:26 amRNSForm 8.3 - EXOVA GROUP PLC
16th May 201710:25 amRNSForm 8.5 (EPT/RI)
15th May 20173:30 pmRNSForm 8.3 - EXO LN
15th May 201711:54 amRNSForm 8.5 (EPT/RI) - Exova Group Plc
15th May 201711:44 amRNSForm 8.3 - Exova Group PLC
15th May 201711:13 amRNSForm 8.5 (EPT/RI)
15th May 201710:41 amRNSForm 8.5 (EPT/RI)
15th May 20179:44 amRNSForm 8.3 - EXOVA GROUP PLC
15th May 20179:39 amRNSDeadline for clarification by Jacobs and PAI
12th May 20173:43 pmRNSRECOMMENDED ACQUISITION OF EXOVA REGULATORY UPDATE
12th May 201711:29 amRNSForm 8.5 (EPT/RI) - Exova Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.